Trial Details

RECRUITING
Basic Information
Clinical ID c724
Identifier NCT03847467
Trial Title Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis
Interventions DRUG: 2'-Fucosyllactose|OTHER: Placebo
Participant Information
Sponsor Children's Hospital Medical Center, Cincinnati
City Hartford
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2019-09-20
Primary Completion Date 2025-03-26
Completion Date 2025-03-27